MedWatch

Here is Novo Nordisk’s strategy for the future

Novo Nordisk has made a plan for the future growth in different branches of the business. The plan includes focus on the traditional core as well as new areas. Moreover, the Danish company has intensified the pursuit of possible acquisitions.

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try us free for 14 days

Try a trial subscription for free access to our quality journalism

Frontpage right now

Nanovi vil lancere kræftmarkør i 2018 efter to års forsinkelse

Det danske selskab Nanovi havde egentlig fået CE-mærkning for sit hovedprodukt i Europa i foråret 2016, men godkendelsen blev siden rullet tilbage. Adm. direktør Jesper Boysen håber at være tilbage på sporet igen med produktet i 2018 - denne gang med en bredere indikation.

Latest Top picks in English

Related articles